This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Osi Pharmaceuticals, Inc., New York University. Active years: 2013-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2022
Title: Dan Sherman: Innovator in Kinase Inhibition
Introduction
Dan Sherman is a notable inventor based in New York, NY (US), recognized for his contributions to the field of kinase inhibition. With a total of 4 patents, he has made significant strides in developing compounds that target specific kinases associated with various diseases.
Latest Patents
Among his latest patents, Sherman has developed inhibitors of CaMKK2, which provide compounds suitable for inhibiting this kinase. The disclosure includes compositions and methods for treating diseases associated with CaMKK2. Additionally, he has worked on macrocyclic kinase inhibitors, which involve compounds of specific formulas, including pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods for treating diseases, particularly cancers where FAK inhibition is beneficial.
Career Highlights
Throughout his career, Dan Sherman has worked with prominent organizations such as Osi Pharmaceuticals, Inc. and New York University. His work has focused on advancing the understanding and treatment of diseases through innovative approaches in kinase inhibition.
Collaborations
Some of his notable coworkers include Andrew Philip Crew and Hanqing Dong, who have contributed to his research endeavors.
Conclusion
Dan Sherman continues to be a significant figure in the field of kinase research, with his innovative patents paving the way for new treatments. His work exemplifies the impact of targeted therapies in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile